XWELL Inc.

NASDAQ: XWEL · Real-Time Price · USD
0.78
0.02 (2.50%)
At close: May 01, 2025, 3:19 PM
0.77
-1.35%
After-hours: May 01, 2025, 07:38 PM EDT

Company Description

XWELL Inc., a health and wellness services company, provides spa services at airports.

It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands.

The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products.

It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services.

In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public.

As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates.

The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022.

XWELL Inc. is headquartered in New York, New York.

XWELL Inc.
XWELL Inc. logo
Country United States
IPO Date Jul 27, 2010
Industry Personal Products & Services
Sector Consumer Cyclical
Employees 246
CEO Ezra T. Ernst

Contact Details

Address:
254 West 31st Street
New York, New York
United States
Website https://www.xwell.com

Stock Details

Ticker Symbol XWEL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001410428
CUSIP Number 98420U802
ISIN Number US98420U8027
Employer ID 00-0000000
SIC Code 7200

Key Executives

Name Position
Ezra T. Ernst President, Chief Executive Officer & Director

Latest SEC Filings

Date Type Title
Apr 29, 2025 S-3/A [Amend] Filing
Apr 28, 2025 10-K/A [Amend] Annual Report
Apr 21, 2025 8-K Current Report
Apr 15, 2025 10-K Annual Report
Apr 15, 2025 8-K Current Report
Apr 11, 2025 8-K Current Report
Mar 31, 2025 NT 10-K Filing
Mar 13, 2025 8-K Current Report
Mar 05, 2025 8-K Current Report
Feb 28, 2025 DEFA14A Filing